Reported effects Improved sleep quality Increased slow-wave (delta) sleep duration Normalization of disrupted sleep patterns Stress reduction and mood support No next-day grogginess Reported side effects Occasional mild headache Occasional mild nausea Mild injection-site reactions (redness, itching) Storage Lyophilised (unmixed) Store dry at -20 C (-4 F), protected from light and moisture
The ratio of diameter change compared with the original size was 0.69 0.02, 0.72 0.02, 0.73 0.04, and 1.35 0.03 in control, 1.0 g/ml BPC 157, 100 g/ml BPC 157 and 200 M SNP, respectively (Fig
This triple mechanism of action distinguishes retatrutide from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 receptor agonist)
Experimental models have shown that DSIP administration increases GABAergic activity while reducing excitatory neurotransmission in cortical and limbic regions
Set realistic expectations that peptides are tools that support rather than magic bullets